LOVE_ASPTE
ID LOVE_ASPTE Reviewed; 503 AA.
AC Q9Y7D3;
DT 01-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1999, sequence version 1.
DT 25-MAY-2022, entry version 69.
DE RecName: Full=Transcriptional regulator LovE {ECO:0000303|PubMed:10334994};
DE AltName: Full=Lovastatin biosynthesis cluster protein E {ECO:0000303|PubMed:10334994};
GN Name=lovE {ECO:0000303|PubMed:10334994};
OS Aspergillus terreus.
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Circumdati.
OX NCBI_TaxID=33178;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], IDENTIFICATION, PATHWAY, AND PROBABLE
RP FUNCTION.
RC STRAIN=ATCC 20542 / MF4845;
RX PubMed=10334994; DOI=10.1126/science.284.5418.1368;
RA Kennedy J., Auclair K., Kendrew S.G., Park C., Vederas J.C.,
RA Hutchinson C.R.;
RT "Modulation of polyketide synthase activity by accessory proteins during
RT lovastatin biosynthesis.";
RL Science 284:1368-1372(1999).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND IDENTIFICATION.
RC STRAIN=CCTCC AF93208;
RX PubMed=19781329;
RA Huang X., Li H.M.;
RT "Cloning and bioinformatic analysis of lovastatin biosynthesis regulatory
RT gene lovE.";
RL Chin. Med. J. 122:1800-1805(2009).
RN [3]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA Sasirekhamani M., Ebenezer P., Devakumar K.M.;
RT "Molecular characterization and bioinformatic analysis of lovastatin
RT biosynthetic regulatory gene lovE in Aspergillus terreus PEMS 01.";
RL Submitted (JUN-2014) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP BIOTECHNOLOGY.
RX PubMed=6933445; DOI=10.1073/pnas.77.7.3957;
RA Alberts A.W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., Rothrock J.,
RA Lopez M., Joshua H., Harris E., Patchett A., Monaghan R., Currie S.,
RA Stapley E., Albers-Schonberg G., Hensens O., Hirshfield J., Hoogsteen K.,
RA Liesch J., Springer J.;
RT "Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-
RT coenzyme A reductase and a cholesterol-lowering agent.";
RL Proc. Natl. Acad. Sci. U.S.A. 77:3957-3961(1980).
RN [5]
RP INDUCTION, AND PROBABLE FUNCTION.
RX PubMed=18414850; DOI=10.1007/s00253-008-1409-2;
RA Barrios-Gonzalez J., Banos J.G., Covarrubias A.A., Garay-Arroyo A.;
RT "Lovastatin biosynthetic genes of Aspergillus terreus are expressed
RT differentially in solid-state and in liquid submerged fermentation.";
RL Appl. Microbiol. Biotechnol. 79:179-186(2008).
RN [6]
RP BIOTECHNOLOGY.
RX PubMed=29236027; DOI=10.3390/ijms18122690;
RA Chen M.C., Tsai Y.C., Tseng J.H., Liou J.J., Horng S., Wen H.C., Fan Y.C.,
RA Zhong W.B., Hsu S.P.;
RT "Simvastatin inhibits cell proliferation and migration in human anaplastic
RT thyroid cancer.";
RL Int. J. Mol. Sci. 18:0-0(2017).
RN [7]
RP BIOTECHNOLOGY.
RX PubMed=29932104; DOI=10.3390/ijms19071834;
RA Zhong W.B., Tsai Y.C., Chin L.H., Tseng J.H., Tang L.W., Horng S.,
RA Fan Y.C., Hsu S.P.;
RT "A synergistic anti-cancer effect of troglitazone and lovastatin in a human
RT anaplastic thyroid cancer cell line and in a mouse xenograft model.";
RL Int. J. Mol. Sci. 19:0-0(2018).
CC -!- FUNCTION: Transcription factor that regulates the expression of the he
CC gene cluster that mediates the biosynthesis of lovastatin (also known
CC as mevinolin, mevacor or monacolin K), a hypolipidemic inhibitor of
CC (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR).
CC {ECO:0000305|PubMed:18414850}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00227}.
CC -!- INDUCTION: Highly expressed during the first day of culture on solid
CC medium; thereafter levels decrease but remain high. Expressed at much
CC lower levels in liquid culture. {ECO:0000269|PubMed:18414850}.
CC -!- BIOTECHNOLOGY: Lovastatin acts as a hypolipidemic agent that works as
CC inhibitor of (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase
CC (HMGR) which reduces HMG-CoA to mevalonate and is the key step in
CC cholesterol biosynthesis (PubMed:6933445). Lovastatin, simvastatin and
CC related compounds are widely used to treat hypercholesteremia and
CC reduce the risk of cardiovascular disease (PubMed:6933445).
CC Furthermore, statins such as lovastatin were found to be anticancer
CC agents (PubMed:29236027, PubMed:29932104).
CC {ECO:0000269|PubMed:29236027, ECO:0000269|PubMed:29932104,
CC ECO:0000269|PubMed:6933445}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF141925; AAD34557.1; -; Genomic_DNA.
DR EMBL; KJ201024; AIC76506.1; -; Genomic_DNA.
DR AlphaFoldDB; Q9Y7D3; -.
DR SMR; Q9Y7D3; -.
DR VEuPathDB; FungiDB:ATEG_09966; -.
DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR CDD; cd00067; GAL4; 1.
DR Gene3D; 4.10.240.10; -; 1.
DR InterPro; IPR001138; Zn2-C6_fun-type_DNA-bd.
DR InterPro; IPR036864; Zn2-C6_fun-type_DNA-bd_sf.
DR Pfam; PF00172; Zn_clus; 1.
DR SMART; SM00066; GAL4; 1.
DR SUPFAM; SSF57701; SSF57701; 1.
DR PROSITE; PS00463; ZN2_CY6_FUNGAL_1; 1.
DR PROSITE; PS50048; ZN2_CY6_FUNGAL_2; 1.
PE 1: Evidence at protein level;
KW DNA-binding; Metal-binding; Nucleus; Transcription;
KW Transcription regulation; Zinc.
FT CHAIN 1..503
FT /note="Transcriptional regulator LovE"
FT /id="PRO_0000430275"
FT DNA_BIND 35..67
FT /note="Zn(2)-C6 fungal-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00227"
FT REGION 89..124
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 331..358
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 99..124
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 503 AA; 55427 MW; E07AA77AD1B92BD2 CRC64;
MAADQGIFTN SVTLSPVEGS RTGGTLPRRA FRRSCDRCHA QKIKCTGNKE VTGRAPCQRC
QQAGLRCVYS ERCPKRKLRQ SRAADLVSAD PDPCLHMSSP PVPSQSLPLD VSESHSSNTS
RQFLDPPDSY DWSWTSIGTD EAIDTDCWGL SQCDGGFSCQ LEPTLPDLPS PFESTVEKAP
LPPVSSDIAR AASAQRELFD DLSAVSQELE EILLAVTVEW PKQEIWTRAS PHSPTASRER
IAQRRQNVWA NWLTDLHMFS LDPIGMFFNA SRRLLTVLRQ QAQADCHQGT LDECLRTKNL
FTAVHCYILN VRILTAISEL LLSQIRRTQN SHMSPLEGSR SQSPSRDDTS SSSGHSSVDT
IPFFSENLPI GELFSYVDPL THALFSACTT LHVGVQLLRE NEITLGVHSA QGIAASISMS
GEPGEDIART GATNSARCEE QPTTPAARVL FMFLSDEGAF QEAKSAGSRG RTIAALRRCY
EDIFSLARKH KHGMLRDLNN IPP